ANAthanasios Notopoulos

Athanasios Notopoulos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Athanasios Notopoulos has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thyroid Imaging Tests

    by Evangelia Zaromytidou, Athanasios Notopoulos

    Thyroid imaging tests provide more information about the thyroid gland’s size, shape, and function. After the thyroid blood tests which are the gold standard for the assessment of conditions like hypothyroidism or hyperthyroidism, imaging tests are recommended to establish a diagnosis. Although the diagnosis of hypothyroidism in itself is not an indication of thyroid imaging, thyroid radionuclide scanning may be useful in elucidating several pathophysiological aspects of hyperthyroidism and in determining the cause of abnormal thyroid function. This may be especially crucial in deciding whether a person will take thyroxine replacement therapy. However, it is important to recognize whether the cause of hypothyroidism is transient or drug-induced because this may require no treatment or only short-term thyroxine supplementation.


  • Open Access

    Vitamin D Alleviates Anxiety and Depression in Elderly People with Prediabetes: A Randomized Controlled Study

    by Evangelia Zaromytidou, Theocharis Koufakis, Georgios Dimakopoulos, Despina Drivakou, Stavroula Konstantinidou, Pantelitsa Rakitzi, Maria Grammatiki, Eleni Manthou, Athanasios Notopoulos, Ioannis Iakovou, et al.

    Older people are prone to frailness, present poor adherence to pharmacotherapy, and often have adverse drug effects. Therefore, it is important to develop effective and safe interventions to mitigate the burden of anxiety and depression disorders in this population. The aim of this study was to investigate the effect of vitamin D supplementation on the anxiety and depression status of elderly people with prediabetes. Participants were randomly assigned a weekly dose of vitamin D3 of 25,000 IU (n = 45, mean age 73.10 ± 7.16 years) or nothing (n = 45, mean age 74.03 ± 7.64 years), in addition to suggested lifestyle measures. The State-Trait Anxiety Inventory subscales (STAI-T and STAI-S) and the Patient Health Questionnaire-9 (PHQ-9) were used to evaluate anxiety and depression levels, respectively, at baseline, 6, and 12 months. A total of 92.68% of the participants in the vitamin D group and 97.14% of the controls exhibited vitamin D deficiency (p = 0.003) and 12 months (32.35 ± 7.77 vs. 44.97 ± 7.78, p < 0.001). The same pattern was evident for STAI-S scores at 6 (37.11 ± 7.88 vs. 43.20 ± 9.33, p = 0.003) and 12 months (32.59 ± 6.45 vs. 44.60 ± 9.53, p < 0.001). Supplemented participants demonstrated lower mean PHQ-9 scores compared to controls at 6 (15.69 ± 6.15 vs. 19.77 ± 8.96, p = 0.021) and 12 months (13.52 ± 5.01 vs. 20.20 ± 8.67, p < 0.001). Participants with deficiency and insufficiency at baseline experienced equal benefits of supplementation in terms of anxiety and depression scores. In conclusion, in a high-risk population, a weekly vitamin D supplementation scheme was effective in alleviating anxiety and depression symptoms. More studies are needed to elucidate the relevant mechanisms.